Menu
Menu
19 Harley St, London, W1G 9QJ, UK

Long term research of the efficacy of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL research.

Long-term research of the efficacy of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL research.

J Headache Ache. 2018 Feb 05;19(1):13

Authors: Blumenfeld AM, Stark RJ, Freeman MC, Orejudos A, Manack Adams A

Summary

BACKGROUND: OnabotulinumtoxinA is authorized for the prevention of headache in these with chronic migraine (CM); nevertheless, extra medical knowledge on the risk-benefit profile for remedy past one yr is fascinating.

METHODS: The Power Migraine OnabotulinuMtoxinA Extended Efficacy open Label (COMPEL) Examine ( ClinicalTrials.gov , NCT01516892) is a world, multicenter, open-label long-term potential research. Adults with CM obtained 155 U of onabotulinumtoxinA (31 websites in a fixed-site, fixed-dose paradigm throughout 7 head/neck muscular tissues) each 12 weeks (±7 days) for 9 remedy cycles (108 weeks). The first final result was headache day reductions at 108 weeks; secondary outcomes have been headache day reductions at 60 weeks and alter within the 6-item Headache Impression Check (HIT-6) rating. Security and tolerability have been assessed by reviewing the frequency and nature of opposed occasions (AEs). AEs have been decided at every go to by affected person self-report, normal non-directed and, for particular AEs, directed questioning, and bodily examination. Subgroup analyses for security and efficacy included, however weren’t restricted to, sufferers with/with out concomitant oral preventive remedy and acute remedy overuse at baseline.
RESULTS: Enrolled sufferers (N?=?716) have been 18-73 years outdated and most have been feminine (n?=?607, 84.eight%). At baseline, sufferers reported a mean 22.zero (SD?=?four.eight) headache days per 30 days. 52.1% of sufferers (n?=?373) accomplished the research. By 60 and 108 weeks, a big discount in headache days (-?9.2 days and -?10.7 days, respectively, P?<?zero.0001) was noticed. Important enhancements (P?<?zero.0001) in HIT-6 scores (-?7.1 level change at week 108) have been additionally demonstrated. 131 sufferers (18.three%) reported ?1 treatment-emergent opposed occasions; most regularly reported was neck ache (n?=?29, four.1%). One affected person reported a critical treatment-related opposed occasion (rash). No deaths have been reported.
CONCLUSIONS: The COMPEL Examine offers further medical proof for the consistency of the efficacy and for the long-term security and tolerability of onabotulinumtoxinA for the prevention of headache in these with CM who’ve been handled with onabotulinumtoxinA each 12 weeks over 2 years (9 therapies) with the fixed-site, fixed-dose injection paradigm.
TRIAL REGISTRATION: Trial registration quantity: NCT01516892 . Identify of registry: clinicaltrials.gov . Date of registration: January 20 2012. Date of enrollment of first affected person: December 2011.

Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study. J Headache Pain. 2018 Feb 05;19(1):13 Authors: Blumenfeld AM, Stark RJ, Freeman MC, Orejudos A,...

What our patients say ...

Consultant Spinal Surgeon
Consultant Spinal Surgeon
Consultant Spinal Surgeon
Consultant Spinal Surgeon
Consultant Spinal Surgeon
Consultant Spinal Anaesthetist

This surgical technique consists of a percutaneous approach for the treatment of small to medium size hernias of the intervertebral disc by laser energy. The main objective is to reduce the intradiscal pressure in the nucleus pulposus

Laser Disc Surgery can be performed under local anaesthetic as a day case at our centre on the prestigious Harley Street.
What is London spine unit and How it Works

The London Spine Unit was established in 2005 and has successfully treated over 5000 patients. All conditions are treated.

treatment of all spinal disorders

The London Spine Unit specialises in Minimally Invasive Treatments allowing rapid recovery and return to normal function

Trusted by patients worldwide

The London Spine Unit provides the highest quality care to all patients and has VIP services for those seeking exceptional services

Laser Spine Surgery Articles

SHADES of grey – The challenge of ‘grumbling’ cauda equina symptoms in older adults with lumbar spinal stenosis.
Abstract Diagnosing cauda equina syndrome is challenging in older adults with lumbar spinal stenosis. Understanding these challenges is vital for
Read more.
The influence of preoperative mental health on clinical outcomes after laminectomy in patients with lumbar spinal stenosis.
Abstract OBJECTIVE: The influence of preoperative mental health on health-related quality of life (HRQOL) in patients with lumbar spinal stenosis
Read more.
MicroRNA transcriptome analysis on hypertrophy of ligamentum flavum in patients with lumbar spinal stenosis.
Abstract Introduction: Molecular pathways involved in ligamentum flavum (LF) hypertrophy are still unclarified. The purpose of this study was to
Read more.
Salvage Strategy for Failed Spinal Fusion Surgery Using Lumbar Lateral Interbody Fusion technique: A Technical Note.
Abstract Introduction: Failed spinal fusion surgery sometimes requires salvage surgery when symptomatic, especially with postsurgical decrease in intervertebral disc height
Read more.
Integrated anatomy of the neuromuscular, visceral, vascular, and urinary tissues determined by MRI for a surgical approach to lateral lumbar
Abstract Introduction: To comprehensively investigate the anatomy of the neuromuscular, visceral, vascular, and urinary tissues and their general influence on
Read more.
Clinical Outcomes of Treating Cervical Adjacent Segment Disease by Anterior Cervical Discectomy and Fusion Versus Total Disc Replacement: A Systematic
Related Articles Clinical Outcomes of Treating Cervical Adjacent Segment Disease by Anterior Cervical Discectomy and Fusion Versus Total Disc Replacement:
Read more.

If you have any emergency Doctor’s need, simply call our 24 hour emergency

Your personal case manager will ensure that you receive the best possible care.

Call Now 

+44 844 589 2020
+44 203 973 8810